Search research articles
Contact Us
Filters
Showing results (1-10 of 282) with videos related to
Page
of 29
Sort By:
Expert Opinion on Therapeutic Targets
|
December 23, 2018
The farnesoid X receptor: a potential target for expanding the therapeutic arsenal against kidney disease
Christos Masaoutis, Stamatios Theocharis
Disease Markers
|
September 6, 2019
The Role of Exosomes in Bone Remodeling: Implications for Bone Physiology and Disease
Christos Masaoutis, Stamatios Theocharis
Nutrition and Cancer
|
November 3, 2011
Current evidence on the anticancer potential of Chios mastic gum
Constantinos Giaginis, Stamatios Theocharis
Expert Opinion on Therapeutic Targets
|
July 18, 2009
Primary liver tumors: origin and target therapy
Michail Papoulas, Stamatios Theocharis
Expert Opinion on Investigational Drugs
|
March 2, 2021
Immunotherapy in uveal melanoma: novel strategies and opportunities for personalized treatment
Christos Masaoutis, Stefania Kokkali, Stamatios Theocharis
World Journal of Gastroenterology
|
August 29, 2006
Insights on augmenter of liver regeneration cloning and function
Elisavet Gatzidou, Gregory Kouraklis, Stamatios Theocharis
Expert Opinion on Investigational Drugs
|
October 10, 2007
Peroxisome proliferator-activated receptor-gamma ligands as investigational modulators of angiogenesis
Costas Giaginis, Alexandra Margeli, Stamatios Theocharis
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
June 29, 2010
Ghrelin, another factor affecting bone metabolism
Dimitrios Nikolopoulos, Stamatios Theocharis, Gregory Kouraklis
Current Molecular Medicine
|
September 11, 2008
Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands: novel pharmacological agents in the treatment of ischemia reperfusion injury
Costas Giaginis, Gerasimos Tsourouflis, Stamatios Theocharis
Histology and Histopathology
|
June 1, 2012
Farnesoid X Receptor (FXR) from normal to malignant state
Ioannis Koutsounas, Constantinos Giaginis, Stamatios Theocharis
Page
of 29
Search research articles
Search
Showing results (1-10 of 282) with videos related to
Sort By:
Page
of 29
Expert Opinion on Therapeutic Targets
|
December 23, 2018
The farnesoid X receptor: a potential target for expanding the therapeutic arsenal against kidney disease
Christos Masaoutis, Stamatios Theocharis
Disease Markers
|
September 6, 2019
The Role of Exosomes in Bone Remodeling: Implications for Bone Physiology and Disease
Christos Masaoutis, Stamatios Theocharis
Nutrition and Cancer
|
November 3, 2011
Current evidence on the anticancer potential of Chios mastic gum
Constantinos Giaginis, Stamatios Theocharis
Expert Opinion on Therapeutic Targets
|
July 18, 2009
Primary liver tumors: origin and target therapy
Michail Papoulas, Stamatios Theocharis
Expert Opinion on Investigational Drugs
|
March 2, 2021
Immunotherapy in uveal melanoma: novel strategies and opportunities for personalized treatment
Christos Masaoutis, Stefania Kokkali, Stamatios Theocharis
World Journal of Gastroenterology
|
August 29, 2006
Insights on augmenter of liver regeneration cloning and function
Elisavet Gatzidou, Gregory Kouraklis, Stamatios Theocharis
Expert Opinion on Investigational Drugs
|
October 10, 2007
Peroxisome proliferator-activated receptor-gamma ligands as investigational modulators of angiogenesis
Costas Giaginis, Alexandra Margeli, Stamatios Theocharis
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
June 29, 2010
Ghrelin, another factor affecting bone metabolism
Dimitrios Nikolopoulos, Stamatios Theocharis, Gregory Kouraklis
Current Molecular Medicine
|
September 11, 2008
Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands: novel pharmacological agents in the treatment of ischemia reperfusion injury
Costas Giaginis, Gerasimos Tsourouflis, Stamatios Theocharis
Histology and Histopathology
|
June 1, 2012
Farnesoid X Receptor (FXR) from normal to malignant state
Ioannis Koutsounas, Constantinos Giaginis, Stamatios Theocharis
Page
of 29